PT-141 is a cutting-edge cyclic melanocortin agonist that exhibits potential in the treatment of sexual dysfunction. This novel compound acts by enhancing specific receptors throughout the body, leading to enhanced sexual function. Research studies have indicated that PT-141 may significantly address a spectrum of sexual dysfunctions in both men a